CN Patent

CN101663026A — 氨基甲酸苯基烷基酯组合物

Assigned to Janssen Pharmaceutica NV · Expires 2010-03-03 · 16y expired

What this patent protects

本发明涉及氨基甲酸苯基烷基酯化合物的组合物，其稳定性提高，其中该组合物包含氨基甲酸苯基烷基酯化合物与有效量的一种或多种赋形剂的混合物，其中至少一种赋形剂是磷酸氢钙二水合物。

USPTO Abstract

本发明涉及氨基甲酸苯基烷基酯化合物的组合物，其稳定性提高，其中该组合物包含氨基甲酸苯基烷基酯化合物与有效量的一种或多种赋形剂的混合物，其中至少一种赋形剂是磷酸氢钙二水合物。

Drugs covered by this patent

benzgalantamine-gluconate (BENZGALANTAMINE GLUCONATE)

Patent Metadata

Patent number: CN101663026A
Jurisdiction: CN
Classification: —
Expires: 2010-03-03
Drug substance claim: No
Drug product claim: No
Assignee: Janssen Pharmaceutica NV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.